Position in EXEL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$300,272
+$293,451 QoQ
Shares Held
7,001
+2409.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Freestone Capital Holdings, LLC holds $6,301,304 across 14 Biotechnology names. EXEL ranks #7 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABUS |
Arbutus Biopharma Corp
|
442,500 | $1,991,250 | |
| 2 | IMNM |
Immunome Inc.
|
61,514 | $1,345,311 | |
| 3 | BNTX |
BioNTech SE
|
7,914 | $703,396 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
900 | $401,886 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
464 | $358,504 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
3,700 | $321,789 | |
| 7 | EXEL |
Exelixis, Inc.
This page
|
7,001 | $300,272 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
2,109 | $205,100 |
All Filings in EXEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $300,272 | 7,001 | Shares | Defined | 2026-05-13 | |
| 2020-09-30 | $6,821 | 279 | Shares | Defined | 2020-11-06 | |
| No filing history on record for this holder in this stock. | ||||||